butt smoking), significant financial savings, and psychological benefits (improved or stable mood).
INTRODUCTION
On any given night in Australia 1 in 200 people are homeless, defined as living in an inadequate or no dwelling or having no or insecure tenure 1 . A 2011 national survey of welfare recipients reporting homelessness reported smoking prevalence of 83% 2 , five times higher than the general population rate of 16% 3 .
Homeless smokers are as interested in quitting smoking as non-homeless smokers [4] [5] [6] .
Three U.S. trials [7] [8] [9] offered homeless smokers cessation pharmacotherapy and counselling (ie.
best-practice treatment 10 ) as well as financial incentives for participation. At 6 month followup all-cases verified 7 day period prevalence abstinence rates were 9.3% 7 , 13.6% 8 and 17.4% 9 . These rates are lower than for the general population, but are impressive given the challenges commonly faced by homeless smokers, e.g. comorbid psychiatric and substance abuse conditions 11 , poor physical health, chronic poverty and social isolation.
The above studies were trials of optimal cessation interventions, i.e., usually offered a selection of free pharmacotherapies and financial incentives for participation, with researchfunded staff probably delivering the interventions. This study examines whether comparable cessation outcomes can be achieved when interventions are offered within the existing resources of a homeless service because homeless services are where programs can be institutionalised, and staff are adept at dealing with the challenges faced by the homeless.
The Royal District Nursing Service Homeless Persons' Program (RDNS-HPP), in
Melbourne, Australia provides holistic primary health care to individuals experiencing (or at risk of) homelessness via outreach and nurse clinics. Following government subsidy of nicotine replacement therapy (NRT) patches in February 2011 nurses noted more clients seeking smoking cessation assistance. As a result RDNS-HPP sought a partnership with Quit Victoria to increase both organisations' capacity to provide smoking cessation assistance to homeless people.
Treatment model
A co-management model involving the nurse, a doctor and Quitline offered participants:
1. A nurse-assisted bulk-billed (free) doctor appointment to review physical and mental health, medications affected by tobacco 12 , and prescribe nicotine patch and/or bupropion, or varenicline for up to 3 months, with government co-payment ($AUD17) covered by the project. Non-subsidised short acting forms of NRT were provided free of charge only if subsidised pharmacotherapies were contraindicated. Nurses assisted with the filling and dispensing of prescriptions. A Quitline referral form was signed by clients agreeing to receive calls and by the GP and nurse, committing them to manage co-morbid health issues and review medications.
Up to 12 weekly smoking cessation appointments with a nurse trained by Quit
Victoria to deliver smoking treatment consistent with Australia's health professional guidelines 13 . Using a client-centred approach nurses assessed smoking behaviour, pharmacotherapy use and mood, and provided stage and contextually appropriate cognitivebehavioural strategies with a focus on strategies that dually act to relieve stress 14 . Eight carbon monoxide (CO) monitors were shared between 14 nurses primarily to assess their value as a motivational tool and secondarily to verify smoking outcomes.
3. Proactive phone support for 3+ months from Quitline to provide client support between appointments and reduce nurse burden. Previous research has demonstrated homeless people's acceptance of phone support for health behaviour change 15 and staff support of referral 16 . Quitline contacted the client to offer the callback service 17 . Free secondhand mobile phones with $20 credit were provided to 15 clients without a mobile phone.
Quitline counsellors received education from RDNS-HPP to improve engagement with and better understand the context of homeless clients. Wherever possible clients spoke with the same counsellor. Calls were offered over a longer duration than for the general population.
Quitline sent a feedback letter to the doctor on their patient's progress.
Evaluation of the treatment model assessed whether it resulted in increased quitting behaviour and associated financial, emotional and physical benefits, and assessed the acceptability and utility of the model from client and nurse perspectives.
METHODS

Design, Participants and Procedure
An uncontrolled before and after study set in the RDNS-HPP in Melbourne, Australia, approved by their ethics committee. Fourteen nurses from a staff of 32 (44%) volunteered to participate. Client ineligibility criteria were: non-smoker, <18 years old, severely and acutely physically or mentally unwell, or lacking capacity to consent.
Between April 2012 and May 2013 14 nurses selectively recruited 49 participants interested in reducing or quitting smoking (mean 3.5 clients per nurse, range 1-7).
Management advised recruitment of three participants consecutively so that smoking treatment could be managed within nurses' existing case load.
Nurses completed three surveys with each client at: program enrolment (baseline), end of the 12-week program (EoP) and six-months post-enrolment. Each survey contained questions for clients plus nurse-only questions. Client retention rates were 61% (n=30) at EoP and 55% (n=27) at 6-months. In addition, eight of each follow-up survey were completed by nurses only, without client data, totalling 76% (n=38) EoP and 71% (n=35) at 6-months.
Nurses also completed a record sheet at each appointment that assessed client smoking behaviour and use of interventions.
Measures
See 
RESULTS
Participant characteristics are presented in Table 1 . The majority (59%, n=29) smoked more than one type of tobacco and the income of 81% ( n=39) fell below the Australian 2013 poverty line ($AUD409 per week). Clients who completed EoP surveys and those who did not showed no significant difference, nor suggestion of trends, on baseline characteristics. At baseline seven participants reported smoking tobacco from discarded butts. Of the four with follow up data two had ceased, one reduced and one had not changed.
Analyses examined associations between uptake of interventions and cessation outcomes. The only effect was more Quitline calls among those reporting 50% consumption reduction at 6 months (10 on average vs. 4 among those not reducing consumption, Mann Whitney U test, n=27, p=.04).
Program impact on mood
At EoP clients were asked how trying to quit or cut down had affected their mood.
Approximately equal numbers reported 'no change' (40%, n=12) or 'better than usual' mood (37%, n=11) with fewer reporting 'worse than usual' mood (23%, n=7). Table 2 suggests improvement in symptoms of anxiety and depression between baseline and EoP (3 months) that appeared to be maintained to 6 months. These findings were not due to differential drop out as baseline levels of anxiety and depression were similar for respondents versus drop outs. Among participants with baseline and EoP anxiety data 71% (n=20) reported the same level of symptoms, 8 (29%) improved and none deteriorated. For depression 13 (48%) stayed the same, 12 (44%) improved and only two (8%) deteriorated between baseline and EoP.
Post-program reflections
At EoP almost all clients rated the program as 'very' (50%, n=15) or 'somewhat' (47%, n=14) worthwhile. Program benefits (regardless of cessation) endorsed by clients included less money spent on tobacco 73% (n=22), improved health 63% (n=19), increased general confidence 37% (n=11) and improved moods 30% (n=9).
Clients using each intervention were asked whether they would have used it if the program hadn't existed. The proportion reporting 'not at all likely' was 94% (n=17/18) for Quitline, 76% (n=16/21) for pharmacotherapy and 54% (n=15/28) for doctor consultation.
Nurse feedback
All thought the program worthwhile, 45% (n=17) 'very' and 55% (n=21) 'somewhat'.
All but one nurse (3%) thought it was 'very easy' (49%, n=18) or 'somewhat easy' (49%, 
DISCUSSION
This study demonstrated that a treatment model for homeless people that combined cessation support from homeless service staff with government subsidised pharmacotherapy and Quitline was both feasible and well-received. Treatment benefits at end of program, which were largely maintained to 6 months, included harm reduction, ie. halving of tobacco consumption and reduced butt smoking, a practice that increases exposure to infectious agents and toxins 24 . Another benefit was reduced tobacco expenditure, from a quarter to an eighth of total income (saving of $AUD32 per week). Treatment was also associated with psychological benefits, namely that any changes in depression or anxiety were very likely improvements. Combined, these benefits made a real difference to the daily lives of homeless smokers.
From a cessation perspective, the 6 month point prevalence abstinence rate of 4% is lower than those reported in other homeless studies -the closest is 9% 7 . However, it is higher than the zero quit rate in a trial of support worker brief advice and free NRT for highly disadvantaged smokers 16 . No clients achieved sustained cessation. Clients in this study were more likely to report at least moderate depression (49% vs 40% in Okuyemi's trial 7 ) , which is known to impede cessation 14 . The current study was unable to offer all participants shortacting NRT, which in combination with the patch can contribute to cessation. Recent research points to other factors that may increase cessation among the homeless such as modest financial incentives 25 , integration of peer support 26 , and reducing negative affect and increasing confidence to cope without cigarettes pre-cessation 27 .
Study limitations include that the trial was conducted in one homeless service motivated to deliver cessation treatment, the low nurse participation rate (44%) and failure to collect data on reasons for nurse non-participation. Nurses selectively sampled clients interested in reducing or quitting smoking and did not record client refusals which anecdotally were low to modest. Only one participant was classified as primary homeless (without conventional shelter). It is quite possible that primary homeless might require extra or differential help. Reports of abstinence were not able to be biochemically verified as we could not afford to provide each nurse with a CO meter. Despite nurses' proactive attempts to contact clients, retention rates were low, however we found no evidence of differences between respondents and non-respondents on baseline measures. In post-program interviews nurses noted clients' mobility, chaotic life circumstances and fluctuating motivation to address their smoking in the face of other crises. Opinion was divided as to whether financial incentives would have increased survey completion rates. Future programs should consider a range of retention strategies 28 .
Findings from this trial debunk commonly-held myths that together with high smoking rates have perpetuated a smoking culture within homeless and mental health settings, for example, that clients are not interested in and/or can't quit, that quitting will compromise clients' mental health and that clients will be unable to cope without cigarettes.
These misguided assumptions have justified inaction on smoking and have hindered disadvantaged smokers' access to tobacco treatment.
A novel and important finding from this trial was that many participants used and rated favourably calls from a Quitline service tailored to meet homeless smokers' needs.
Participants who used Quitline more were more likely to report a 50% or more reduction in tobacco consumption at 6 months. These findings demonstrate the potential value of Quitline as a resource for disadvantaged populations and the organisations who serve them. Routine referral to Quitline of smokers who are interested in quitting can help overcome staff barriers to addressing tobacco use 29, 30 .
In sum, the treatment model tested in this study provides a demonstration of what can realistically be achieved by services with limited resources. In its current form the treatment model was acceptable to nurses and provided important harm reduction and material and psychological benefits for clients, but further research is required to find sustainable interventions that also increase cessation. 
